IKENA ONCOLOGY

Ikena Oncology is a targeted oncology company focused on developing cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Ikena is advancing five programs that include four product candidates in either clinical development or IND-enabling studies: IK-930, a TEAD inhibitor targeting the Hippo signaling pathway; an ERK5 inhibitor program targeting the KRAS signaling pathway; IK-175, an AHR antagonist; IK-412, a kynurenine-degrading enzyme; and IK-007, an EP4 receptor antagonist. Ikena has entered into a global strategic collaboration with Bristol-Myers Squibb Company for its IK-175 and IK-412 programs.

#SimilarOrganizations #People #Financial #Event #Website #More

IKENA ONCOLOGY

Social Links:

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

2016-01-01

Address:

Boston, Massachusetts, United States

Country:

United States

Website Url:

http://www.ikenaoncology.com

Total Employee:

11+

Status:

Active

Contact:

1-857-273-8343

Email Addresses:

[email protected]

Total Funding:

169 M USD

Technology used in webpage:

SPF Wordpress Plugins Nginx Microsoft Exchange Online Office 365 Mail GoDaddy DNS Mimecast

Similar Organizations

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Current Advisors List

not_available_image

George C. Prendergast Advisor @ Ikena Oncology
Advisor

david-bonita_image

David Bonita Board Member @ Ikena Oncology
Board_member

richard-wooster_image

Richard Wooster Board Member @ Ikena Oncology
Board_member
2022-01-01

Current Employees Featured

mark-manfredi_image

Mark Manfredi
Mark Manfredi President, Founding Member & CEO @ Ikena Oncology
President, Founding Member & CEO
2016-03-01

michelle-zhang_image

Michelle Zhang
Michelle Zhang Senior Vice President, Translational Research and Early Development @ Ikena Oncology
Senior Vice President, Translational Research and Early Development
2019-09-01

karen-mcgovern_image

Karen McGovern
Karen McGovern Vice President Of Drug Discovery @ Ikena Oncology
Vice President Of Drug Discovery
2016-11-01

not_available_image

Jotin Marango
Jotin Marango Chief Financial Officer and Head of Corporate Development @ Ikena Oncology
Chief Financial Officer and Head of Corporate Development
2022-04-01

Founder

mark-manfredi_image

Mark Manfredi

michelle-zhang_image

Michelle Zhang

Stock Details

Company's stock symbol is NASDAQ:IKNA

Investors List

bristol-myers-squibb_image

Key Employee Changes

Date	New article
2022-04-13	Ikena Appoints Jotin Marango, M.D., Ph.D., as Chief Financial Officer and Head of Corporate Development

Official Site Inspections

http://www.ikenaoncology.com Semrush global rank: 352.8 K Semrush visits lastest month: 167.49 K

Host Informations
Whois Informations

Loading ...

IKENA ONCOLOGY

IKENA ONCOLOGY

Social Links:

Industry:

Founded:

Address:

Country:

Website Url:

Total Employee:

Status:

Contact:

Email Addresses:

Total Funding:

Technology used in webpage:

Similar Organizations

ALX Oncology

Current Advisors List

Current Employees Featured

Founder

Stock Details

Investors List

Bristol Myers Squibb

Cowen Healthcare Investments

Invus

Farallon Capital Management

Surveyor Capital

Fidelity Management and Research Company

OrbiMed

HealthCor Partners

Logos Capital

BVF Partners

Key Employee Changes

Official Site Inspections

More informations about "Ikena Oncology" on Search Engine

America

Europe

Asia

Others

IKENA ONCOLOGY

IKENA ONCOLOGY

Social Links:

Industry:

Founded:

Address:

Country:

Website Url:

Total Employee:

Status:

Contact:

Email Addresses:

Total Funding:

Technology used in webpage:

Similar Organizations

Current Advisors List

Current Employees Featured

Founder

Stock Details

Investors List

Key Employee Changes

Official Site Inspections

More informations about "Ikena Oncology" on Search Engine